Evidence map›Paper›PMID 32286326›Full record

ArticleNature communications2020

Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation.

Minhui Chen, Guanxi Qiao, Bonnie L Hylander, Hemn Mohammadpour, Xiang-Yang Wang, John R Subjeck, Anurag K Singh, Elizabeth A Repasky

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Stress induces corticosterone-mediated CD8Cancer immunology, immunotherapy : CII · 2025
    Article
  18. Review
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Minhui ChenDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Guanxi QiaoDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Bonnie L HylanderDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Hemn MohammadpourDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Xiang-Yang WangDepartment of Genetics, Virginia Commonwealth University, Richmond, VI, 23298, USA.
John R SubjeckDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Anurag K SinghDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA.
Elizabeth A RepaskyDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY, 14263, USA. elizabeth.repasky@roswellpark.org.

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Large heat shock proteins and their role in cancer therapyR01CA099326 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A, WANG, XIANG-YANG SHAWN · 2003 to 2020
$5.7M
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitorsR01CA205246 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI REPASKY, ELIZABETH A · 2018 to 2022
$2.8M
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune responseR01CA236390 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI GERBER, SCOTT ANDREW, REPASKY, ELIZABETH A · 2019 to 2023
$2.8M
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapyR01CA229812 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FANG, XIANJUN, WANG, XIANG-YANG SHAWN · 2019 to 2023
$2.0M
IVIS Spectrum Imaging SystemS10OD016450 · OD · ROSWELL PARK CANCER INSTITUTE CORP · PI SPERNYAK, JOSEPH ANDREW · 2013 to 2013
$406k
Overcoming stress driven suppression of the anti-tumor immune response in cancer - understanding the MDSC piece of the puzzleF32CA239356 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOHAMMADPOUR, HEMN · 2020 to 2021
$80k
NCI NIH HHS F32 CA239356NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA099326NCI NIH HHS R01 CA205246NCI NIH HHS R01 CA229812NCI NIH HHS R01 CA236390NIH HHS S10 OD016450
6 · The paper itself

Abstract

The abscopal effect following ionizing radiation therapy (RT) is considered to be a rare event. This effect does occur more frequently when combined with other therapies, including immunotherapy. Here we demonstrate that the frequency of abscopal events following RT alone is highly dependent upon the degree of adrenergic stress in the tumor-bearing host. Using a combination of physiologic, pharmacologic and genetic strategies, we observe improvements in the control of both irradiated and non-irradiated distant tumors, including metastatic tumors, when adrenergic stress or signaling through β-adrenergic receptor is reduced. Further, we observe cellular and molecular evidence of improved, antigen-specific, anti-tumor immune responses which also depend upon T cell egress from draining lymph nodes. These data suggest that blockade of β2 adrenergic stress signaling could be a useful, safe, and feasible strategy to improve efficacy in cancer patients undergoing radiation therapy.

Indexed as

ImmunityRadiation, IonizingStress, PhysiologicalAdrenergic AgentsAdrenergic beta-AntagonistsAnimalsCD8-Positive T-LymphocytesCell Line, TumorCell ProliferationDisease Models, AnimalGene Expression Regulation, NeoplasticLymph NodesMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutNeoplasmsAdrenergic AgentsAdrenergic beta-AntagonistsReceptors, Adrenergic, beta-2

Identifiers

PMID32286326
PMCPMC7156731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.